ArticleScientific reports2026
Nox4 and circulating free MPO synergistically promote aortic aneurysm formation.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
21 authors.
Funding
Abstract
Myeloperoxidase (MPO)-induced oxidative stress plays an important role in the pathogenesis of abdominal aortic aneurysms (AAA). MPO protein released from activated inflammatory cells can circulate and be taken up into blood vessels, but the mechanisms that regulate vascular MPO uptake, and how this might impact abdominal aortic aneurysms (AAA) formation, are poorly understood. Given that MPO utilizes hydrogen peroxide (H2O2) to generate the oxidant hypochlorous acid (HOCl), and that Nox4 is a major producer of vascular H2O2, we hypothesized that vascular Nox4 promotes MPO uptake to cooperate in AAA formation. We found that aortic MPO uptake along with Nox4 expression and H2O2 levels were significantly increased in angiotensin II (AngII)-induced AAA mice. Increased aortic MPO uptake was also confirmed by ex vivo incubation of AngII- or calcium chloride (CaCl2)-treated aorta. Notably, global deletion of Nox4 prevented AngII-induced aortic MPO uptake ex vivo, while Nox4 KO mice were protected against AngII-induced AAA formation. Furthermore, overexpression of human MPO by liver-specific AAV in MPO KO mice increased circulating MPO levels and aortic MPO accumulation while promoting AAA formation. Vascular Nox4 expression contributes to aortic MPO uptake, providing a novel mechanistic linkage whereby MPO and Nox4 cooperate to promote AAA.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.